[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "Based on the information provided, the most likely diagnosis is Primary Central Nervous System Lymphoma (PCNSL) associated with HIV. The presence of lymphocytic predominant pleocytosis, positive Epstein-Barr virus DNA in the cerebrospinal fluid, and a solitary, ring-enhancing lesion in the brain are all suggestive of PCNSL. PCNSL is a type of lymphoma that primarily affects the brain and central nervous system, and it is more common in immunocompromised individuals, such as those with HIV/AIDS.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "For the gp41 subunit of the HIV envelope glycoprotein, the medication prescribed is Enfuvirtide (also known as T-20).",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "Based on the information provided, the patient is most likely in the asymptomatic or chronic stage of HIV infection, often referred to as HIV-1 infection or asymptomatic HIV infection. This stage typically occurs after the acute phase of HIV infection and before the onset of AIDS. The patient's CD4 count of 650/mm3 is relatively high, indicating that the immune system is still functioning relatively well.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "Based on the patient's symptoms and lab results, the most likely diagnosis is HIV-associated nontuberculous mycobacterial (NTM) pneumonia, given the presence of cavitations on the chest radiograph and the identification of partially acid-fast gram-positive branching rods on bronchoalveolar lavage.\n\nThe most appropriate drug for managing NTM pneumonia is clarithromycin, an macrolide antibiotic. \n\nThe mechanism of action of clarithromycin is inhibiting protein synthesis in bacteria by binding to the 50S ribosomal subunit of bacteria, thereby preventing the formation of the 50S ribosomal subunit and inhibiting the translation of mRNA into proteins.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "The most likely target of the antibody the physician scientist is designing would be the HIV gp120 or gp41 proteins. These proteins are part of the HIV envelope and are the primary targets of the humoral immune response. The gp120 protein is responsible for binding to the CD4 receptor on host cells, while gp41 facilitates the fusion of the viral envelope with the host cell membrane.\n\nThe gp41 protein is a more likely target for antibody design because it is more conserved across different HIV strains, making it a more attractive target for a broadly neutralizing antibody. Additionally, antibodies targeting gp41 have been shown to be effective in neutralizing HIV in vitro and in vivo.\n\nHowever, it's worth noting that designing a more potent antibody against HIV is a complex task and would require a deep understanding of the immune response and the structure-function relationships of the HIV envelope proteins.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "Based on the clinical presentation and biopsy findings, the most likely causal organism is Aspergillus. The presence of septate hyphae that branch at acute angles is characteristic of Aspergillus species, which are common causes of invasive aspergillosis in immunocompromised individuals, such as those with HIV.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "The patient is already on a regimen of zidovudine, lamivudine, and dolutegravir. Adding valganciclovir to this regimen increases the risk of:\n\n- Increased risk of myelosuppression (anemia, neutropenia) due to the combination of zidovudine and valganciclovir, both of which can cause bone marrow suppression.\n- Potential for increased risk of lactic acidosis or liver toxicity, as zidovudine and lamivudine are both associated with these side effects, and adding valganciclovir may exacerbate these risks.\n\nMonitoring for these adverse effects, such as regular blood counts and liver function tests, is essential when initiating valganciclovir in this patient.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "For the newborn to be tested for HIV, the most appropriate diagnostic test is a PCR (Polymerase Chain Reaction) test for HIV RNA, also known as a viral load test. This test can detect the presence of HIV RNA in the baby's blood within 24-48 hours of birth.",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "This situation raises concerns about confidentiality and duty to inform others at risk. \n\nIn this case, the physician has a duty to inform the patient's wife about the risk of HIV exposure. This is because the patient's wife is at risk of HIV transmission due to the potential exposure during the affair. The physician should not disclose the patient's HIV status directly to the wife, but should inform her about the potential risk and the importance of getting tested.\n\nThe physician should have an open and honest conversation with the patient about this, explaining the duty to inform his wife and the potential consequences of not doing so. The physician should also offer to facilitate a conversation between the patient and his wife, or refer them to a counselor or a specialist in infectious disease for further guidance.",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "Based on the patient's presentation and laboratory findings, the most likely etiology of this patient's condition is acute pancreatitis, likely caused by alcohol use. The patient's history of moderate social alcohol use and the absence of gallstones (normal gallbladder on CT) makes alcoholic pancreatitis the primary consideration. The elevated serum amylase and lipase levels support this diagnosis. The patient's HIV status may also play a role in her susceptibility to pancreatitis, as individuals with HIV infection may be more prone to pancreatitis due to various factors, including the virus itself and antiretroviral medications. However, without knowing the specific HIV medications she is taking, it's difficult to say if they are contributing to her pancreatitis.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "The drug zidovudine (also known as AZT) is a nucleoside reverse transcriptase inhibitor (NRTI). Its mechanism of action is to inhibit the reverse transcription of viral RNA into DNA by competing with the natural nucleoside substrates for the reverse transcriptase enzyme. This disruption prevents the HIV virus from replicating.\n\nMore specifically, the biological process disrupted by zidovudine is the conversion of viral RNA into double-stranded DNA, which is essential for the integration of HIV into the host cell's genome and subsequent viral replication.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "DNA methylation is a type of epigenetic modification that plays a crucial role in regulating gene expression. Research has shown that DNA methylation profiles can be altered in individuals with HIV-1 infection.\n\nStudies have found that patients with latent HIV-1 infection tend to have distinct DNA methylation profiles compared to those with active infection or uninfected individuals. Specifically:\n\n1.  **Latent HIV-1 infection:** DNA methylation patterns in latent HIV-1 infection tend to be more pronounced in the promoter regions of genes involved in immune response and inflammation, such as IL-6, TNF-\u03b1, and IFN-\u03b3. This may contribute to the persistence of the virus in a dormant state.\n2.  **Active HIV-1 infection:** In contrast, patients with active HIV-1 infection often exhibit altered DNA methylation patterns in genes related to immune response and cell proliferation, such as CD4 and CD8 T cells. This may contribute to the immune dysregulation and inflammation observed in active infection.\n3.  **Epigenetic reactivation:** Some studies suggest that certain DNA methylation patterns can be associated with the reactivation of latent HIV-1, particularly in the presence of immune activation or antiretroviral therapy (ART) discontinuation.\n\nIt's essential to note that these findings are based on observational studies, and more research is needed to fully understand the relationship between DNA methylation and HIV-1 infection. However, epigenetic modifications, including DNA methylation, may provide valuable insights into the mechanisms underlying HIV-1 persistence and reactivation.\n\nIf you're interested in learning more, I recommend looking into recent publications from reputable journals such as Nature, Science, or the Journal of Clinical Investigation.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]